SARS-CoV-2 seroprevalence and implications for population immunity: Evidence from two Health and Demographic Surveillance System sites in Kenya, February-December 2022 (2023)
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1111/irv.13173
Publication URI: http://dx.doi.org/10.1111/irv.13173
Type: Journal Article/Review
Parent Publication: Influenza and Other Respiratory Viruses
Issue: 9